Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?
Frontiers in Bioengineering and Biotechnology · 26.09.2023 · 11
DOI: 10.3389/fbioe.2023.1254356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 26.09.2023. Verfasst von Haorong Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan,…. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chemotherapy often faces some obstacles such as low targeting effects and drug resistance, which introduce the low therapeutic efficiency and strong side effects. Recent advances in nanotechnology allows the use of novel nanosystems for targeted drug delivery, although the chemically synthesized nanomaterials always show unexpected low biocompability. The emergence of exosome research has offered a better understanding of disease treatment and created novel opportunities for developing effective drug delivery systems with high biocompability. Moreover, RNA interference has emerged as a promising strategy for disease treatments by selectively knocking down or over-expressing specific genes, which allows new possibilities to directly control cell signaling events or drug resistance. Recently, more and more interests have been paid to develop optimal delivery nanosystems with high efficiency and high biocompability for drug and functional RNA co-delivery to achieve enhanced chemotherapy. In light of the challenges for developing drug and RNA co-delivery system, exosomes have been found to show very attractive prospects. This review aims to explore current technologies and challenges in the use of exosomes as drug and RNA co-delivery system with a focus on the emerging trends and issues associated with their further applications, which may contribute to the accelerated developments of exosome-based theraputics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China.
- Institute of Laboratory Medicine, School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, China.
- The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, Guangdong, China.
Zitieren
APA
Chen, H., Yao, H., Chi, J., Li, C., Liu, Y., Yang, J., Yu, J., Wang, J., Ruan, Y., Pi, J., & Xu, J. F. (2023). Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1254356
Vancouver
Chen H, Yao H, Chi J, Li C, Liu Y, Yang J, et al. Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1254356
BibTeX
@article{Chen2023,
author = {Chen, Haorong and Yao, Hanbo and Chi, Jiaxin and Li, Chaowei and Liu, Yilin and Yang, Jiayi and Yu, Jiaqi and Wang, Jiajun and Ruan, Yongdui and Pi, Jiang and Xu, Jun-Fa},
title = {Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2023},
volume = {11},
doi = {10.3389/fbioe.2023.1254356}
}
EUVIMED